Table 1.
Study design
DE dabigatran etexilate, bid twice daily, qd once daily
aTest dabigatran pharmacokinetic parameters determined from samples taken after the co-administered doses on day 4
bReference dabigatran pharmacokinetic parameters determined from samples taken after the morning dose on day 3